Successful Implementation of a Perioperative Glycemic Control Protocol in Cardiac Surgery: Barrier Analysis and Intervention Using Lean Six Sigma by Martinez, Elizabeth A. et al.
Hindawi Publishing Corporation
Anesthesiology Research and Practice
Volume 2011, Article ID 565069, 10 pages
doi:10.1155/2011/565069
Clinical Study
SuccessfulImplementation of a Perioperative Glycemic Control
Protocol in Cardiac Surgery:BarrierAnalysisandIntervention
UsingLeanSix Sigma
ElizabethA. Martinez,1 Raul Chavez-Valdez,2,3 NatalieF. Holt,4
Kelly L. Grogan,5 Katherine W. Khalifeh,6 Tammy Slater,7 LauraE. Winner,8
Jennifer Moyer,7 andChristoph U. Lehmann3
1 DepartmentofAnesthesia,CriticalCareandPainMedicine,MassachusettsGeneralHospital,HarvardMedicalSchool,55FruitStreet,
GRB 4-44, Boston, MA 02114, USA
2 Division of Neonatology, Department of Pediatrics, Texas Tech University Health Sciences Center, 701 West 5th Street, Odessa,
TX 79765, USA
3 Division of Neonatology, Department of Pediatrics, Johns Hopkins Medicine, 600 North Wolfe Street, Nelson 2-133, Baltimore,
MD 21287-3200, USA
4 Department of Anesthesiology, West Haven Veterans Aﬀairs Medical Center, Yale University School of Medicine, 333 Cedar Street,
TMP 3, P.O. Box 208051, New Haven, CT 06520-8051, USA
5 Department of Anesthesia, Medical University of South Carolina (MUSC), 25 Courtenay Drive, Suite 4200, MSC 240, Charleston,
SC 29425-2400, USA
6 Department of Surgery, Johns Hopkins Medicine, 600 North Wolfe Street, Blalock 655, Baltimore, MD 21287, USA
7 Cardiac Surgical ICU, Department of Nursing, Johns Hopkins Medicine, 600 N. Wolfe Street, Halsted 600, Baltimore,
MD 21287, USA
8 Director Lean Sigma Program, Center for Innovation in Quality Patient Care, Johns Hopkins Medicine, 601 North Caroline Street,
Suite 2080, Baltimore, MD 21287-0765, USA
Correspondence should be addressed to Elizabeth A. Martinez, martinez.elizabeth@mgh.harvard.edu
Received 15 April 2011; Accepted 22 June 2011
Academic Editor: Alparslan Turan
Copyright © 2011 Elizabeth A. Martinez et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Although the evidence strongly supports perioperative glycemic control among cardiac surgical patients, there is scant literature
to describe the practical application of such a protocol in the complex ICU environment. This paper describes the use of the Lean
Six Sigma methodology to implement a perioperative insulin protocol in a cardiac surgical intensive care unit (CSICU) in a large
academichospital.Apreinterventionchartauditrevealedthatfewerthan10%ofpatientswereadmittedtotheCSICUwithglucose
<200mg/dL, prompting the initiation of the quality improvement project. Following protocol implementation, more than 90%
of patients were admitted with a glucose <200mg/dL. Key elements to success include barrier analysis and intervention, provider
education, and broadening the project scope to address the intraoperative period.
1.Introduction
Methods to develop evidence-supported practices for quality
improvement projects became prevalent in the 1990s, yet,
two decades later, signiﬁcant gaps persist in translating
the best evidence into practice [1]. This is particularly
true for complex disease states (such as insulin resistance)
coupled with complex procedures (such as cardiac surgery).
In addition, the majority of clinical research has focused
on understanding disease processes and identifying eﬀec-
tive therapies, yet there is relatively little emphasis on
the implementation side. The available literature tends to
recommend using system-wide changes to alter provider
behaviors [2]. System change is becoming increasingly2 Anesthesiology Research and Practice
important as public reporting of compliance with evidence-
based protocols and “pay-for-performance” reimbursement
gain ground. Yet, ultimately, to change provider behavior,
we must ﬁrst understand facilitators and barriers. To this
end,Cabanaandcolleagues[3,4]exploredphysicianbarriers
to the implementation of best practices and proposed
general approaches to modifying individual provider behav-
ior. Unfortunately, such generalizations do not address the
unique complexities of the intensive care unit (ICU), where
a conﬂuence of provider preferences, patient comorbidities,
and system factors make an interdisciplinary local approach
more eﬀective.
Diﬀerent methods have been proposed to facilitate
clinical guideline implementation, for example, Plan-Do-
Study-Act, total quality management, and continuous qual-
ity improvement [5, 6]. One performance improvement
approach that has proven eﬀective in driving high reliability
is Lean Six Sigma (LSS) [7–9]. The LSS method incorporates
data-driven methods which focus on reducing defects and
undesirable variation within a process.
Because LSS is designed to function in complex envi-
ronments, the methodology is promising for application
in healthcare systems. The LSS approach addresses opera-
tional aspects including change management, identiﬁcation
of barriers, and other limiting factors; it also provides
straightforward analytical tools and improvement moni-
toring methods [10, 11]. Because the evidence strongly
supports achieving glycemic control in cardiac surgical
patients to improve outcomes [12, 13], we selected the
LSS as a strategy for implementing an insulin protocol
in a cardiac surgical ICU (CSICU) in a large academic
hospital. We hypothesized that the comprehensive LSS
approach would generate a substantial and sustainable
improvement in perioperative glucose control, speciﬁcally
that we would increase the number of CSICU admissions
with a glucose <200mg/dL, decrease the time to control
and percentage of patients in control at 6 hours post-
ICU admission (deﬁned as 80–110mg/dL), and improve the
overall time in control while not increasing hypoglycemic
events. While published reviews have proposed “pointers”
for implementation of an ICU insulin protocol [14], this
paper is the ﬁrst to detail how LSS methods can be used
to improve glycemic control in a complex patient-care
setting.
A glucose control guideline was developed in 2002
for the CSICU. In June 2003, 6 months after rollout, a
multidisciplinary team (nursing, surgery, anesthesiology,
and hospital quality improvement) conducted a chart audit
(Figure 1) and concluded that glycemic control remained
poor despite the compelling evidence in the literature and
the CSICU’s new guideline. Consequently, a formal LSS-
structured improvement initiative was launched. This paper
presents the process of identifying barriers and improving
clinician compliance with a new formal protocol, as well as
our practical experience using LSS to identify and overcome
these barriers. While suggested target glucose levels have
changed since the protocol was originally designed [15],
the methodology and performance monitoring presented
here remain relevant.
2. Methods
In 2003, as part of a performance improvement project,
we evaluated the current process of glycemic control in the
CSICU of a tertiary care center. To manage the project, data
were collected prospectively with periodic chart reviews
using standardized tools during the study period June
2003–2007. After Institutional Review Board (IRB) approval,
additional electronic data were captured retrospectively for
this publication according to the processes outlined next.
2.1. Lean Six Sigma Methods. The multidisciplinary team
sought to improve glycemic control using the LSS DMAIC
framework (deﬁne, measure, analyze, improve, and control)
in the tertiary care center’s CSICU. Each step of the DMAIC
process is detailed herein.
Deﬁne. The team developed a project charter to capture the
magnitude of the problem, and deﬁne the local contributing
factors and opportunities for improvement. A baseline chart
audit was conducted (KK) which suggested that the majority
of patients were severely hyperglycemic upon CSICU admis-
sion (33% of patients with admission glucose <200mg/dL,
Figure 1). Thus, for the initial project charter, we deﬁned
ﬁve measurable goals (outcome measures, or “Y”s) of the
improvement program as follows.
(1) Improve glucose control upon admission to the
CSICU: increase the number of patients with glucose
<200mg/dL on admission to the ICU from 33%
to 73%; (a 40% increase). (This target was selected
according to LSS principles: the goal was to improve
performance by 80%; thus, the LSS recommendation
for the initial intervention is to set a preliminary goal
halfway to the ultimate objective.)
(2) Improve glucose control following admission to the
CSICU:increasetheproportion ofpatientsincontrol
(glucose between 80 and 110mg/dL) at 6 hours post-
CSICUadmissionfrom0%to20%;(a20%increase).
(3) Reduce the time to control (measured in hours from
admission).
(4) Improve the mean time-weighted glucose level
(TWGL).
(5) Reach and hold a steady state of hypoglycemic events
<2% as deﬁned by the existing hospital tracking
system (percentage of total glucose values).
Measure. The performance improvement interventions and
thus the measurement phases were iterative (Figure 1,
Table 1). This work was completed during monthly QI team
meetings and in small working groups.
(i) Identiﬁcation of Baseline Capability (or “Y”s) and
Following Protocol Modiﬁcations (Phases of Interven-
tion). Glucose values and associated time points
post-ICU admission, deviation from protocol, and
presence of vasoactive agents were collected viaAnesthesiology Research and Practice 3
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Figure 1: Prospective audit data by implementation phase of CSICU Lean Six Sigma glucose control project.
periodic real-time chart audits using a standardized
instrument. Data were then entered into an Excel
spreadsheet. Since both point-of-care glucometer
data and core laboratory data were used by bedside
practitioners to make insulin adjustments, both
sources of glucose measurement were included in the
analysis.
(ii) Identiﬁcation of Key Contributing Factors (or “X”s)
to Inadequate Control. Possible factors shown (or
perceived) to be contributing to poor control were
generated during QI meetings and augmented by
a nursing survey (see next, assessment of current
practice). These factors are depicted in a ﬁshbone
(cause-and-eﬀect) diagram (Figure 2)a n df o r c eﬁ e l d
analysis (Figure 3).
(iii) Assessment of Current Practice. In addition to the
baseline chart audit, a QI team member (NH)
established a focus group with the ICU nursing staﬀ
and developed an evaluation tool (survey) to identify
the CSICU nurses’ state of knowledge regarding
the evidence for glucose control, understanding
of the existing guideline, and barriers to protocol
implementation. This evaluation tool identiﬁed that
staﬀ believed the glucose control guideline was
“just a research project” that one of the physicians
developed rather than an evidence-based recommen-
dation to improve patient outcomes. Furthermore,
nurses believed that the absence of an intraoperative
glucose management strategy conﬁrmed the lack of
importance of the issue. In addition, the existing
CSICU guideline lacked clarity on many aspects
(Figure 3). Fewer than half of the nurses (41%) felt
the current protocol was successful; many nurses felt
adherence to the CSICU insulin guideline impeded
rather than improved their chance of achieving
glycemic control. These barriers are represented in
Figure 3 and categorized as logistical, mental models
and knowledge gap restraining forces. An additional
criticism identiﬁed through the focus groups was
that none of the bedside nurses participated in
the development of the existing guideline and no
usability testing had been performed.
(iv) Development of a Process Map for Implementing an
Insulin Protocol. A process map of the steps required
by nurses to implement the current glucose guideline
was developed; another process map identiﬁed time-
limiting steps and potential barriers to successful4 Anesthesiology Research and Practice
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Figure 2: Fishbone diagram of glucose protocol implementation process.
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Figure 3: Force ﬁeld analysis based on CSICU nursing assessment.
implementation of the formal protocol. The nursing
staﬀ identiﬁed key issues including the following:
(1) an order allowing them to follow the glucose
control guideline was frequently not written at
admission (partly owing to ambiguity of which
patients qualiﬁed for the protocol); (2) delays or
shortages of insulin infusion pumps from pharmacy
allowed glucose levels to climb following admission
to the ICU.
Analyze. The key contributing factors to poor glucose con-
trol, the ﬁndings from the front-line provider survey and
interviews, barriers, and process maps were discussed at
the QI team meetings. Data from prospective audits of
glucose control were reviewed on an ongoing basis to inform
changesintheinsulinprotocol(Figure 1).Datafortheaudits
were obtained from the electronic records. Data abstracted
included glucose values, concomitant vasoactive infusions,
insulin dosing, and compliance with the protocol including
time of lab draws.
2.2. Statistical Analysis. Qualitative analyses were performed
on ﬁndings from focus groups. Real-time chart audit
data were reviewed informally with individual nurses and
practitioners to keep the process moving forward. This was
done on an ongoing basis. Nursing champions would discuss
these data at regularly scheduled staﬀ meetings. More formal
interim reviews and real-time audits included trend analysesAnesthesiology Research and Practice 5
Table 1: CSICU glucose protocol timeline.
Phase and
Date Primary intervention Study period
Baseline
Nursing assessment via
survey. Measure
admission glucose level
in CSICU
1/8/03–6/27/03
Phase 1
(7/25/03)
OR protocol (begin
insulin for glucose
>180mg/dL)∗
8/15/03–11/29/03
Phase 2
(12/15/03)
CSICU nursing
education and
implementation of new
CSICU glycemic
control protocol
1/12/04–4/15/04
Phase 3
(5/1/05)
OR protocol (begin
insulin for glucose
>150mg/dL)∗
5/15/05–8/12/05
Phase 4
(9/1/05)
Introduction of revised
CSICU protocol
10/7/05–12/31/05
Phase 5
(2/1/06)
OR protocol (begin
insulin for glucose
>120mg/dL)∗
2/16/06–6/15/06
Final
(11/1/06)
OR protocol (begin
insulin for glucose
>100mg/dL)∗
2/19/07–3/31/07
∗Goal admission glucose <200mg/dL.
and case reviews to inform modiﬁcations of the glucose
control protocols (Figure 4).
For the cumulative retrospective analysis, we evaluated
the following variables: time-weighted glucose level (TWGL)
[16]; mean and median glucose levels for the length of stay;
admission glucose level; time to glucose control (time to
control) from CSICU admission (hours); percent of hypo-
glycemic patients and incidents per phase of intervention.
(The TWGL was selected to represent the overall glycemic
control of the patient because it takes into account the
increased clinical likelihood for patients with an abnormal
value to have more frequent rechecks, while those with
normal values have fewer repeat measures. Using averages
or means would therefore skew data to the abnormal
values.) The goal glucose on admission was <200mg/dL and
“in control” was deﬁned as 80–110mg/dL for the quality
improvement time period. Data for the retrospective analysis
were obtained through abstraction of lab values from the
electronicrecord.Forcontinuous variables,datadistribution
and variance homogeneity were determined by the Shapiro-
Wilk and Levene tests, respectively. All continuous variables
included in this analysis were found to be nonnormally
distributed; thus, all multiple group (phase) comparisons
were made by Kruskal-Wallis ANOVA and post hoc tests
assuming unequal variance by Tamhane’s T2 test. Data are
displayed with box-and-whisker plots in which the box and
line inside the box represent the interquartile range (IQR,
25th and 75th percentile) and the median, respectively.
Whiskers extend up to the last data point available within
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Figure 4: Informing protocol modiﬁcation with real-time audit
data: initial and 6-hour glucose. Audits 1–5 reﬂect targeted data
collection at Baseline (June 2003); Phase 2 (June 2004); Phase 3
(January 2005); Phase 4 (June 2005); Final (December 2007).
1.5 times the IQR from the median. Outliers were removed
from the plots in order to allow marks to be placed. For
binomial variables, data were analyzed by Chi square test in
all cases and represented as bar graphs where appropriate.
Statistical signiﬁcance was deﬁned as P < 0.05. Analyses
were performed using IBM SPSS Statistics 18 software (IBM
Corporation, Somers, NY, USA).
Improve. Based on ﬁndings from interim reviews during the
measure and analyze phases, a multipronged and sequential
approach was taken to improve glucose control. The OR and
ICUprotocolsweremodiﬁedperiodically;projectphasesand
key interventions are noted in Figure 1 and Table 1.
(i) Implemented formal glucose control protocol in the
OR during Phase 1, thus driving the intervention
focus further “upstream” from the CSICU. Prior
to implementation, the CSICU data and proposed
anesthesia-developed OR protocols were reviewed
with the entire cardiac anesthesia division. Given
the concerns about the lability of the intraoperative
period and the heightened risk of unrecognized
hypoglycemia in patients under anesthesia, the group
agreed to an initial target CSICU admission glucose
of <200mg/dL. In order to increase the comfort level
of the providers, the protocol was initially developed
such that insulin would be initiated in the OR for
glucoses >180mg/dL with the intention of frequent
assessment for safety.
(ii) CSICU nursing education was formalized in Phase 2.
Multiple educational events included distribution of
the new formalprotocol and integrating the rationale
behind the glycemic control protocol during nursing
skills days and new staﬀ orientations.
(iii) Implemented formal glucose control protocol in the
CSICU with ongoing assessment plan and feedback
to nursing staﬀ in Phase 2. A complete redesign6 Anesthesiology Research and Practice
of the glucose control protocol was undertaken
with CSICU nursing input. Introduction of the
new formal protocol was planned to coincide with
a previously planned nursing skills day to gener-
ate enthusiasm and allow staﬀ to ask questions.
Following implementation, ﬁve intermittent real-
t i m ea u d i t sw e r ep e r f o r m e d( F i g u r e s1 and 4)t o
assess compliance with the new formal protocol and
to identify potential risks including hypoglycemic
events. This process included real-time discussions
with bedside providers to gain continued insight
into the limitations of the protocol and its successful
implementation, updates at bimonthly staﬀ meet-
ings, and posting of data in central areas. The issue
of glucose control was added to the CSICU daily
goal sheet [17] to make certain that a discussion
about glycemic control was included during morning
rounds. “Glucose rounds” were also implemented
during which time the CSICU nurse manager or
charge nurse would lead a discussion among the
nursing staﬀ regarding a particularly challenging
case or would review data pertaining to achieving
glycemic control (sample case review provided in
Figure 5). Early on, the focus of the audits and
glucose rounds was to emphasize the importance of
following the protocol so that it could be accurately
evaluated. Frequently nursing staﬀ would state that
the protocol was too aggressive and resulted in
hypoglycemic episodes. However, through a review
of speciﬁc cases, it was identiﬁed that many of these
events occurred because the protocol had not been
followed accurately—most frequently due to failures
in glucose monitoring which the nurses ascribed to
lack of time or availability of glucometers (Figure 3).
This ﬁnding resulted in purchasing additional bed-
side glucometers so that nurses would not have to
leave a patient’s room in order to carry out the
test.
Control. In order to maintain the momentum, education on
glucose management was incorporated into the orientation
of all new nursing staﬀ. In addition, ongoing education and
data updates were included in bimonthly staﬀ meetings. In
the surgical suite, the insulin protocol was posted in all
ORs for easy access and included in resident orientation
materials. In addition, following the ﬁnal audit, admission
glucoses were tracked on a monthly basis (data not shown)
as an extension of the performance improvement project
to quickly identify any deterioration in performance. Each
patient who did not meet set criteria was investigated.
3. Results
The implementation timeline and ﬁve real-time audit data
are presented in Figures 1 and 4. Data from the real-time
audits informed the ongoing quality improvement process
while the retrospective analysis was used to evaluate the
overall impact of the LSS project. The seven data collection
periods (Baseline, Phases 1–5, and Final) are included in the
r e t r o s p e c t i v ea n a l y s i s( Table 2 and Figures 1, 6,a n d7).
3.1. Real-Time Chart Audits. Five prospective audits were
performed (Figures 1 and 4). At audit no. 1, only 33% of
patients had an admission glucose of <200mg/dl, compared
to 88% in audit no. 5. At audit no. 1 (baseline), no patients
had a glucose <110mg/dL at 6 hours compared to 41%
in audit no. 5. Additional results of the prospective audits
are shown in Figure 4 (admission and 6-hour glucoses).
An example of the instruments used for “CSICU glucose
rounds” is shown in Figure 5.
3.2. Retrospective Analysis. We performed a global retro-
spective analysis of 1892 patients who were admitted to
the CSICU during the phases described in Table 1. At the
completion of the LSSprogram, glucose data wereabstracted
from the electronic medical record. There were a total
of 81,333 glucose checks and a mean (±SD) of 8(±5)
glucoses per patient-day. The average number of glucose
measurements/patient/day increased signiﬁcantly over the
study period from 3(±4) at baseline and phase 1 to 12(±4)
during the ﬁnal phase (P < 0.001) (Table 2). Using the
retrospective data, at baseline, 76% of patients had an
admission glucose of <200mg/dL compared to 94% in the
ﬁnal phase (P < 0.001), an improvement of 18%. No patients
had a glucose <1 1 0m g / d La t6h o u r sa tb a s e l i n ec o m p a r e d
to 11% in the ﬁnal phase (P < 0.001). The impact of the
protocol is substantiated by two additional outcomes: (1)
TWGL from a median of 138 (32) to 109 (13) (Figure 6) and,
(2) signiﬁcant improvement in the time to achieving glucose
control from a median (IQR) of 16 (22) hours at baseline to
9 (4) hours in the ﬁnal phase (Figure 7).
The impact of the sequential changes in the OR protocol
is evident by the data throughout Table 2. While the number
of hypoglycemic events remained low (1.7% at baseline and
0.9% at Phases 5 and Final), the proportion of patients with
a hypoglycemic event increased signiﬁcantly from 9.5% at
baseline to 19% at ﬁnal (P < 0.001).
4. Discussion
This work represents the use of LSS methodology to
successfully implement a glycemic control protocol in a
CSICU. While many articles have highlighted the evidence
to support perioperative glucose control in cardiac surgical
patients[15,18–21]andsomehaveincludedactualprotocols
utilized [18, 22, 23], we are unaware of any prior articles
detailing the multifaceted process of implementing a com-
prehensive insulin protocol in a critical care setting. This
paperdemonstratesthatLSSmethodologycanbeaneﬀective
tool in achieving new process implementation. In particular,
we emphasize how barriers to success can be successfully
identiﬁed and overcome.
Implementation of an insulin protocol in an ICU setting
is challenging due to the complex nature of both the
guideline and the environment. Achieving success withAnesthesiology Research and Practice 7
Figure 5: Sample case for review during “CICU Glucose Rounds.”
glucosecontrolisdiﬃcultforseveralreasons.First,providers
are skeptical about the beneﬁts of maintaining glycemic
control and express concerns about increasing the risk
for hypoglycemia, with its potentially devastating sequelae.
Second,glucosemanagementisacomplex,multistep process
withindependentprobabilitiesoffailureassociatedwitheach
step and patient coupled with a dynamic set of variables
persistently changing a patient’s insulin requirements. Third,
achieving optimal glucose control is a labor-intensive pro-
cess, requiring human and equipment resources that are
often scarce in a high-acuity environment. While targeted
g l u c o s ev a l u e sh a v eb e e nm o d i ﬁ e do v e rt h ey e a r s[ 15, 24],
the approach to addressing barriers and optimization of
glucose management are unchanged. By using LSS tools, we
developed unforeseen insights into the problem of achieving
glycemic control in the CSICU, such as the importance of
beginning the process of glucose management in the OR and
incorporating the knowledge and concerns of key stakehold-
ers (frontline providers) into the design and implementation
of a glucose protocol.8 Anesthesiology Research and Practice
Table 2: Retrospective evaluation of glucose data by project phase.
Baseline Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 Final P value
Patients n 390 221 267 221 204 279 310 —
Glucose
datapoints n 3778 2505 11063 13255 13509 18180 19043 —
Datapoints/
patient/day Mean (±SD) 3( ±2) 3 (±2) 8 (±3) 12 (±5) 11 (±5) 11 (±5) 12 (±4) <0.001a
Admit glucose
(mg/dL)
Median
(IQR)
160 (67) 144 (56) 161 (57) 144 (58) 136 (57) 133 (49) 124 (48) <0.001b
Admit glucose
<200mg/dL %( n) 76 (297) 89 (197) 81 (217) 87 (192) 90 (184) 95 (266) 94 (291) <0.001c
TWGL (mg/dL) Mean (±SD) 141 (±26) 133 (±27) 129 (±22) 116 (±12) 112 (±11) 111 (±11) 111 (±11) <0.001a
Median
(IQR)
138 (32) 129 (37) 129 (20) 115 (15) 110 (11) 109 (14) 109 (13) <0.001b
Time to glucose
control (hr)
Median
(IQR)
16 (22) 15 (17) 12 (11) 11 (10) 9 (9) 10 (8) 9 (8) <0.001b
Glucose 6h
control %( n) 0 (0) 0.5 (1) 7.1 (19) 4.5 (10) 5.9 (12) 8.6 (24) 11 (34) <0.001c
Hypoglycemia
events %( n) 1.7 (63) 1.5 (38) 1.5 (168) 1.2 (161) 0.7 (90) 0.9 (160) 0.9(173) <0.001c
Hypoglycemic
patients %(n) 9.5 (37) 10.9 (24) 21.3 (57) 23.1 (51) 21.6 (44) 16.8 (47) 19 (59) <0.001c
aOne-way ANOVA; bKruskal−Wallis ANOVA; cChi−square.
IQR: Interquartile range; Max: maximum; n: number of patients; SD: standard deviation; TWGL: time−weighted glucose levels.
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Figure 6: TWGL by phase of intervention (retrospective data
analysis). Box-and-whisker plot represents TGWL (mg/dL) by
phase. ∗P < 0.05 and ∗∗P < 0.01 (versus baseline) and †P < 0.05
and ††P < 0.01 (versus ﬁnal phase).
Several factors must be considered when interpreting our
data. First, we chose to use LSS methodology to achieve
our glycemic control goal and were successful with this
method. However, we did not compare this methodology
to other established QI methodologies such as PDSA and
total quality management [5, 6], and it is likely that these
other approaches could be similarly eﬀective. The advantage
oﬀered by LSS was that many of the QI team were trained
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Figure 7: Time to control (retrospective data analysis). Box-and-
whisker plot represents time to control (mg/dL) by phase. ∗P <
0.05 and ∗∗P < 0.01 (versus baseline) and †P < 0.05 and ††P < 0.01
(versus ﬁnal phase).
in this method and thus shared the same framework for
discussing the problem. We felt this was an important
element,andwhendesigningqualityimprovementinitiatives
it is essential for all members of the team to share the
same mental model for the approach. Furthermore, we felt
the LSS tools would be useful in identifying local barriers
to success, which we believed ap r i o r iwere signiﬁcant
contributing factors to the failure to achieve glycemicAnesthesiology Research and Practice 9
control with the initial implementation of a glucose control
guideline. Such speciﬁc tools are lacking in other general
quality improvement methodologies. Second, our report
highlights the variation in outcomes (glucose control) when
performing audits in real-time as compared to collecting
data on a larger ICU patient population retrospectively. For
example,ourreal-timeauditsunderestimatedtheproportion
of patients with glucose levels <200mg/dL (33% compared
to 76% in the retrospective cohort). While the real-time
data is invaluable, this is a potentially important aspect to
consider when implementing new protocols—the baseline
audit is a snapshot in time. Institutions may wish to
couple a retrospective review for a similar time period
(if seasonality is likely to be a factor) with a real-time
assessment to get a balanced picture of current performance.
The discrepancy we found is likely due to sampling error as
the audit was conducted based on a census prevalence (20
patients in the CSICU) compared to 390 patients included
in the retrospective baseline cohort; it could also reﬂect
the random chance that higher risk patients were admitted
to the CSICU the week of the audit. Incorporating data
requirements into electronic health records could greatly
facilitate the process of data management and analysis for QI
programs. Third, recommendations for the best measure of
eﬀectivenessandriskofaninsulinprotocolvarywidelyinthe
literature [13, 16, 25, 26]. In our analysis, we used admission
glucose, the time to control, and the TWGL and we report
percent of glucoses to represent hypoglycemic events. When
determining our local acceptable rate of hypoglycemia, we
used the global measure of percentage of glucose checks
sincethesedatawerereadilyavailable.However,thismeasure
may be misleading since we had a notable percentage of
patientswithglucosevalueslessthan60mg/dL(withanearly
increase to >20% and 19% in the ﬁnal phase). While we
stated in our charter that we did not want to increase our
rate of hypoglycemia, our baseline rate was extremely low
since so few patients were on an insulin infusion prior to
the implementation of this process improvement initiative.
Additionally, patients on average had only 3(±2) glucose
measures/day, compared to 12(±4) in the ﬁnal phase of
our initiative. A fourth limitation is that we elected not to
collect demographic data on our CSICU patient population
because our intention was to develop a protocol that was
eﬀectiveforallpatientsadmittedtotheCSICU,andtherefore
would be inherently insensitive to demographic indicators.
Demographic data might have oﬀered important insights
into the predictors of hypoglycemia and poor control. The
perception of the LSS team was that the complexity of the
patients increased during the study period, with an increased
cohort of patients with heart failure requiring higher doses
of epinephrine, our ﬁrst line inotrope. If we had been able to
identify them, it might have yielded beneﬁcial information
for others developing protocols. Furthermore, we may have
exhibited even greater relative improvements had we been
able to risk adjust for patient severity and include a measure
of vasoactive support. A ﬁfth limitation is that we did
not collect outcomes such as infection and mortality rates.
However, the intermediate outcome of glucose control has
been shown to be associated with a reduction in morbidity
and mortality [15] and was more directly relevant to our
stated project goal.
5. Conclusion
Implementation of evidence-based practices is very complex
and failure prone. Evidence is necessary but not suﬃcient to
complete implementation: the evidence provides the “what
to do” but not the “how to do.” The lack of translational
science providing the path from evidence to the bedside may
be the reason why the literature suggests it takes one to two
decades for evidence-based guidelines to be incorporated
into clinical practice [1].
In order to deliver evidence-based practices consistently,
we recommend locally developed or modiﬁed (i.e., ICU-
and OR-speciﬁc) protocols, routine evaluation (and reeval-
uation) of barriers, and engagement of a multidisciplinary
team to design intervention plans and evaluation measures.
This study demonstrates the practicality and eﬀectiveness
of using LSS techniques to substantially eﬀect change in a
complex clinical environment.
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